https://bioutah.org/myriad-genetics-launches-prolaris-ai-the-first-prostate-cancer-test-to-combine-genomics-and-digital-pathology-artificial-intelligence-ai/2026-05-28T18:45:13ZBioUtahenMyriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)2026-05-28T18:45:13ZBloghttps://bioutah.org/co-diagnostics-advances-ebola-pcr-assay-development-strategy-with-joint-venture-cosara/2026-05-28T18:43:59ZBioUtahenCo-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara2026-05-28T18:43:59ZBloghttps://bioutah.org/nanokar-therapeutics-announces-formal-appointment-of-craig-mosman-as-chief-executive-officer/2026-05-28T14:38:14ZBioUtahenNanoKar Therapeutics Announces Formal Appointment of Craig Mosman as Chief Executive Officer2026-05-28T14:38:14ZBlog